Clinical Trial Update: Effect of Weight and/or Obesity on Dapsone Drug Concentrations [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated whether weight and obesity influence dapsone drug concentrations, involving participants with obesity and leprosy; results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leprosy
• Obesity

Drugs mentioned

• DAPSONE (dapsone)

Snippet

Sponsor: Texas Tech University Health Sciences Center | Conditions: Obesity, Leprosy | Phase 4 | Status: COMPLETED | Results posted: 2016-07-21